# UNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Novel Therapeutics and Biomarkers

> **NCT07652151** · NA · RECRUITING · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 450 (estimated)

## Conditions studied

- MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)

## Interventions

- **BEHAVIORAL:** Multimodal lifestyle intervention

## Key facts

- **NCT ID:** NCT07652151
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-20
- **Primary completion:** 2026-11
- **Final completion:** 2027-02
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-06-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652151, "UNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Novel Therapeutics and Biomarkers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*